Bertucci, Francois

Dirix, Luc

Harano, Kenichi

Hess, Kenneth R.

Iwase, Toshiaki

Kida, Kumiko

Krishnamurthy, Savitri

Layman, Rachel M.

Lucci, Anthony

Masuda, Hiroko

Ueno, Naoto T.

van Laere, Steven

Wang, Ying

Woodward, Wendy A.

Abstract: Background The purpose of this study was to determine the prognostic role of hormone receptor (HR) on inflammatory breast cancer (IBC) to elucidate its aggressive biological behavior. Methods We evaluated the expression of estrogen receptor (ER) and progesterone receptor (PR) by immunohistochemical staining and determined the predictive and prognostic role of HR expression on 189 patients with HR+/HER2- IBC and 677 patients with HR+/HER2- stage III non-IBC. Furthermore, we performed gene expression (GE) analyses on 137 patients with HR+/HER2- IBC and 252 patients with HR+/HER2- non-IBC to detect genes that are specifically overexpressed in IBC. Results The expression of ER% was significantly associated with longer distant disease-free survival and overall survival. However, there was no significant relationship between ER% and neoadjuvant chemotherapy outcome. In the GE study, 84 genes were identified as significantly distinguishing HR+ IBC from non-IBC. Among the top 15 canonical pathways expressed in IBC, the ERK/MAPK, PDGF, insulin receptor, and IL-7 signaling pathways were associated with the ER signaling pathway. Upregulation of the MYC gene was observed in three of these four pathways. Furthermore, HR+/HER2- IBC had significantly higher MYC amplification, and the genetic alteration was associated with poor survival outcome. Conclusions Higher ER expression was significantly associated with improved survival in both HR+/HER2- IBC and HR+/HER2- stage III non-IBC patients. HR+/HER2- IBC had several activated pathways with MYC upregulation, and the genetic alteration was associated with poor survival outcome. The results indicate that MYC may be a key gene for understanding the biology of HR+/HER2- IBC

Institutional Repository Universiteit Antwerpen

Quantitative hormone receptor (HR) expression and gene expression analysis in HR plus inflammatory breast cancer (IBC) vs non-IBC

Quantitative hormone receptor (HR) expression and gene expression analysis in HR plus inflammatory breast cancer (IBC) vs non-IBC

Abstract

Similar works

Full text

Available Versions

Institutional Repository Universiteit Antwerpen